J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Medical Genetics 2006;43:e16; doi:10.1136/jmg.2005.035006
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by (R) Yang, X
Right arrow Articles by Goldstein, A M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by (R) Yang, X
Right arrow Articles by Goldstein, A M

ELECTRONIC LETTER

Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome

X (R) Yang, R M Pfeiffer, A M Goldstein

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA

Correspondence to:
Dr Xiaohong (Rose) Yang
Genetic Epidemiology Branch, DCEG, NCI, 6120 Executive Blvd., Rm 7014, Bethesda, MD 20852, USA; royang{at}mail.nih.gov] Background: The naevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant multisystem disorder with variable expression. NBCCS patients have variable susceptibility to development of basal cell carcinoma (BCC). Previous studies have shown that polymorphisms of some metabolic genes encoding the cytochrome p450 (CYP) and glutathione-S-transferase (GST) enzymes influenced the numbers of BCCs in sporadic BCC cases.

Objective: To determine whether allelic variants of these genes contribute to the variation in numbers of BCCs observed in NBCCS families.

Methods: Genotyping and analysis was carried out in 152 members (69 affected and 83 unaffected) of 13 families with NBCCS for seven polymorphisms in five metabolic genes including CYP1A1, CYP2D6, GSTM1, GSTP1, and GSTT1.

Results: GSTP1 Val105 and GSTP1 Val114 alleles were significantly associated with fewer BCC numbers (odds ratio (OR)105 = 0.55 (95% confidence interval, 0.35 to 0.88); OR114 = 0.20 (0.05 to 0.88)). The Val105 allele showed a dose dependent effect (ORIle/Val = 0.58 (0.34 to 0.88); ORVal/Val = 0.34 (0.14 to 0.78)). In addition, fewer jaw cysts were observed in carriers of the three p450 polymorphisms (CYP1A1m1, CYP1A1m2, and CYP2D6*4) (ORCYP1A1m1 = 0.27 (0.12 to 0.58); ORCYP1A1m2 = 0.25 (0.08 to 0.78); ORCYP2D6*4 = 0.33 (0.18 to 0.60)).

Conclusions: Genetic variants might contribute to the variation in numbers of BCCs and jaw cysts observed in NBCCS families.


Abbreviations: BCC, basal cell carcinoma; BPDE, benzo(a)pyrene diol epoxide; GEE, generalised estimating equations; GST, glutathione-S-transferase; NBCCS, naevoid basal cell carcinoma syndrome; PAH, polycyclic aromatic hydrocarbon

Keywords: glutathione-S-transferase; cytochrome p45; genetic polymorphism; naevoid basal cell carcinoma syndrome




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. M. Moyer, O. E. Salavaggione, T.-Y. Wu, I. Moon, B. W. Eckloff, M. A.T. Hildebrandt, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum
Glutathione S-Transferase P1: Gene Sequence Variation and Functional Genomic Studies
Cancer Res., June 15, 2008; 68(12): 4791 - 4801.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.